Celltrion | 068270 - Operating Profit

Stock Price
188,800.00
Daily Change
-6,300.00 -3.23%
Monthly
-9.67%
Yearly
22.60%
Q2 Forecast
177,698.56

Celltrion reported KRW13.72B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Celltrion KRW 13.72B 287.31B Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 217M 171M Dec/2025
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025